Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

about

The love-hate relationship between bacterial polysaccharides and the host immune system.Implications of plant glycans in the development of innovative vaccines.

P2860

Q36615936-61E93376-39A7-4CFE-8EC6-381CE7E7A8D8 Q38738762-28C44217-5A75-46D0-B23E-1C881C09B886

P2860

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

Item

http://www.wikidata.org/entity/Q36181172

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@ast

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@en

type

Item

label

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@ast

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@en

prefLabel

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@ast

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@en

P1476

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

@en

P2093

Fattom A

http://www.w3.org/2001/XMLSchema#string

Sood RK

http://www.w3.org/2001/XMLSchema#string

P2860

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

Polysialic acid units are spatially and temporally expressed in developing postnatal rat kidney.

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates

Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.

Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

P304

333-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.7.3.333

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15991976

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

about

P2860

P2860

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921